Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands.
Valbiotis R&D Riom Center, Riom, France.
Int J Obes (Lond). 2021 Sep;45(9):2016-2027. doi: 10.1038/s41366-021-00870-x. Epub 2021 Jun 2.
BACKGROUND/OBJECTIVES: The worldwide prevalence of obesity, metabolic syndrome and type 2 diabetes (T2D) is reaching epidemic proportions that urge the development of new management strategies. Totum-63 is a novel, plant-based polyphenol-rich active principle that has been shown to reduce body weight, fasting glycemia, glucose intolerance, and fatty liver index in obese subjects with prediabetes. Here, we investigated the effects and underlying mechanism(s) of Totum-63 on metabolic homeostasis in insulin-resistant obese mice.
Male C57Bl6/J mice were fed a high-fat diet for 12 weeks followed by supplementation with Totum-63 for 4 weeks. The effects on whole-body energy and metabolic homeostasis, as well as on tissue-specific inflammation and insulin sensitivity were assessed using a variety of immunometabolic phenotyping tools.
Totum-63 decreased body weight and fat mass in obese mice, without affecting lean mass, food intake and locomotor activity, and increased fecal energy excretion and whole-body fatty acid oxidation. Totum-63 reduced fasting plasma glucose, insulin and leptin levels, and improved whole-body insulin sensitivity and peripheral glucose uptake. The expression of insulin receptor β and the insulin-induced phosphorylation of Akt/PKB were increased in liver, skeletal muscle, white adipose tissue (WAT) and brown adipose tissue (BAT). Hepatic steatosis was also decreased by Totum-63 and associated with a lower expression of genes involved in fatty acid uptake, de novo lipogenesis, inflammation, and fibrosis. Furthermore, a significant reduction in pro-inflammatory macrophages was also observed in epidydimal WAT. Finally, a potent decrease in BAT mass associated with enhanced tissue expression of thermogenic genes was found, suggesting BAT activation by Totum-63.
Our results show that Totum-63 reduces inflammation and improves insulin sensitivity and glucose homeostasis in obese mice through pleiotropic effects on various metabolic organs. Altogether, plant-derived Totum-63 might constitute a promising novel nutritional supplement for alleviating metabolic dysfunctions in obese people with or without T2D.
背景/目的:肥胖症、代谢综合征和 2 型糖尿病(T2D)在全球的流行程度正在达到流行的程度,这促使人们开发新的管理策略。Totum-63 是一种新型的、富含多酚的植物活性成分,已被证明可降低糖尿病前期肥胖患者的体重、空腹血糖、葡萄糖耐量和脂肪肝指数。在这里,我们研究了 Totum-63 对胰岛素抵抗肥胖小鼠代谢稳态的影响及其潜在机制。
雄性 C57Bl6/J 小鼠喂食高脂肪饮食 12 周,然后补充 Totum-63 4 周。使用各种免疫代谢表型工具评估对全身能量和代谢稳态以及组织特异性炎症和胰岛素敏感性的影响。
Totum-63 可降低肥胖小鼠的体重和脂肪量,而不影响瘦体重、食物摄入量和运动活性,并增加粪便能量排泄和全身脂肪酸氧化。Totum-63 降低了空腹血糖、胰岛素和瘦素水平,改善了全身胰岛素敏感性和外周葡萄糖摄取。肝脏、骨骼肌、白色脂肪组织(WAT)和棕色脂肪组织(BAT)中胰岛素受体β的表达和胰岛素诱导的 Akt/PKB 磷酸化增加。Totum-63 还降低了肝脂肪变性,并与参与脂肪酸摄取、从头脂肪生成、炎症和纤维化的基因表达降低有关。此外,还观察到附睾 WAT 中促炎巨噬细胞显著减少。最后,发现 BAT 质量显著减少,同时组织中热原基因的表达增强,提示 Totum-63 激活 BAT。
我们的结果表明,Totum-63 通过对各种代谢器官的多种作用降低肥胖小鼠的炎症,提高胰岛素敏感性和葡萄糖稳态。总之,源自植物的 Totum-63 可能成为缓解肥胖人群或伴有 T2D 肥胖人群代谢功能障碍的有前途的新型营养补充剂。